Deutsche Bank
FLGT icon

Deutsche Bank’s Fulgent Genetics FLGT Stock Holding History

Deutsche Bank’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Sell
27,197
-298,249
-92% -$5.06M ﹤0.01% 2706
2026
Q1 		$5.17M Sell
325,446
-113,550
-26% -$2.46M ﹤0.01% 1283
2025
Q4 		$11.5M Sell
438,996
-65,489
-13% -$1.7M ﹤0.01% 1030
2025
Q3 		$11.4M Buy
504,485
+172,928
+52% +$3.56M ﹤0.01% 1015
2025
Q2 		$6.59M Buy
331,557
+61,787
+23% +$1.2M ﹤0.01% 1126
2025
Q1 		$4.56M Buy
269,770
+138,340
+105% +$2.36M ﹤0.01% 1288
2024
Q4 		$2.43M Buy
131,430
+7,532
+6% +$147K ﹤0.01% 1710
2024
Q3 		$2.69M Buy
123,898
+3,164
+3% +$70.7K ﹤0.01% 1582
2024
Q2 		$2.37M Buy
120,734
+26,463
+28% +$552K ﹤0.01% 1559
2024
Q1 		$2.05M Buy
94,271
+24,294
+35% +$603K ﹤0.01% 1647
2023
Q4 		$2.02M Buy
69,977
+59,515
+569% +$1.59M ﹤0.01% 1677
2023
Q3 		$280K Buy
10,462
+744
+8% +$25.4K ﹤0.01% 2559
2023
Q2 		$360K Sell
9,718
-16,168
-62% -$564K ﹤0.01% 2544
2023
Q1 		$808K Buy
25,886
+3,853
+17% +$124K ﹤0.01% 2225
2022
Q4 		$656K Buy
22,033
+822
+4% +$29.4K ﹤0.01% 2305
2022
Q3 		$808K Sell
21,211
-1,644
-7% -$82.4K ﹤0.01% 2095
2022
Q2 		$1.25M Sell
22,855
-1,235
-5% -$67.9K ﹤0.01% 2032
2022
Q1 		$1.5M Buy
24,090
+10,435
+76% +$687K ﹤0.01% 2071
2021
Q4 		$1.37M Sell
13,655
-4,603
-25% -$405K ﹤0.01% 2239
2021
Q3 		$1.64M Sell
18,258
-53,562
-75% -$4.87M ﹤0.01% 2255
2021
Q2 		$6.62M Buy
71,820
+34,303
+91% +$2.74M ﹤0.01% 1374
2021
Q1 		$3.63M Buy
37,517
+26,571
+243% +$2.74M ﹤0.01% 1758
2020
Q4 		$570K Buy
10,946
+5,550
+103% +$232K ﹤0.01% 2823
2020
Q3 		$216K Sell
5,396
-6,763
-56% -$212K ﹤0.01% 3173
2020
Q2 		$194K Buy
12,159
+11,487
+1,709% +$176K ﹤0.01% 3156
2020
Q1 		$7K Buy
672
+285
+74% +$3.97K ﹤0.01% 4100
2019
Q4 		$4K Sell
387
-3,522
-90% -$41.9K ﹤0.01% 4703
2019
Q3 		$40K Buy
3,909
+3,899
+38,990% +$37K ﹤0.01% 4047
2019
Q2 		$0 Sell
10
-10,300
-100% -$62.7K ﹤0.01% 5346
2019
Q1 		$61K Buy
+10,310
New +$47.3K ﹤0.01% 4495
2018
Q2 		– Sell
-10
Closed – – 5473
2018
Q1 		$0 Hold
10
– – ﹤0.01% 5466
2017
Q4 		$0 Hold
10
– – ﹤0.01% 5031
2017
Q3 		$0 Sell
10
-5,031
-100% -$28.9K ﹤0.01% 4942
2017
Q2 		$32K Buy
5,041
+4,083
+426% +$32.9K ﹤0.01% 4479
2017
Q1 		$10K Sell
958
-6,783
-88% -$80.2K ﹤0.01% 4618
2016
Q4 		$88K Buy
+7,741
New +$73.1K ﹤0.01% 4142

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

Deutsche Bank's FLGT Position: Q2 2026 in Review

Deutsche Bank reduced its Fulgent Genetics (FLGT) stake by 92% in Q2 2026, selling an estimated $5.06M and leaving 27,197 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

Deutsche Bank first reported a position in FLGT in Q4 2016 and has held it in 36 quarters since. The position peaked at $11.5M in Q4 2025. 46 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Deutsche Bank held 27,197 shares of Fulgent Genetics worth $558K as of Q2 2026.
  • Deutsche Bank sold 298,249 Fulgent Genetics shares in Q2 2026, an estimated $5.06M.
  • Fulgent Genetics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2706 holding.
  • Deutsche Bank first reported a position in Fulgent Genetics in Q4 2016 and has held it in 36 quarters since.
  • Deutsche Bank's Fulgent Genetics position peaked at $11.5M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.